These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12721796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Crystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.
    Luz JG, Yu M, Su Y, Wu Z, Zhou Z, Sun R, Wilson IA.
    J Mol Biol; 2005 Oct 07; 352(5):1019-28. PubMed ID: 16140327
    [Abstract] [Full Text] [Related]

  • 4. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.
    Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA.
    J Exp Med; 1999 Jun 21; 189(12):1993-8. PubMed ID: 10377196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.
    Haque NS, Fallon JT, Taubman MB, Harpel PC.
    Blood; 2001 Jan 01; 97(1):39-45. PubMed ID: 11133740
    [Abstract] [Full Text] [Related]

  • 9. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines.
    Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ.
    J Biol Chem; 1999 Jul 30; 274(31):21569-74. PubMed ID: 10419462
    [Abstract] [Full Text] [Related]

  • 10. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.
    Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA.
    Science; 1997 Oct 10; 278(5336):290-4. PubMed ID: 9323208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
    Davis CN, Zujovic V, Harrison JK.
    Mol Pharmacol; 2004 Dec 10; 66(6):1431-9. PubMed ID: 15361546
    [Abstract] [Full Text] [Related]

  • 14. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.
    Louahed J, Struyf S, Demoulin JB, Parmentier M, Van Snick J, Van Damme J, Renauld JC.
    Eur J Immunol; 2003 Feb 10; 33(2):494-501. PubMed ID: 12645948
    [Abstract] [Full Text] [Related]

  • 15. Do viral chemokines modulate Kaposi's sarcoma?
    Dittmer D, Kedes DH.
    Bioessays; 1998 May 10; 20(5):367-70. PubMed ID: 9670810
    [Abstract] [Full Text] [Related]

  • 16. Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice.
    Takami S, Minami M, Nagata I, Namura S, Satoh M.
    J Cereb Blood Flow Metab; 2001 Dec 10; 21(12):1430-5. PubMed ID: 11740204
    [Abstract] [Full Text] [Related]

  • 17. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
    Ko J, Jang SW, Kim YS, Kim IS, Sung HJ, Kim HH, Park JY, Lee YH, Kim J, Na DS.
    FASEB J; 2004 May 10; 18(7):890-2. PubMed ID: 15001559
    [Abstract] [Full Text] [Related]

  • 18. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein.
    LiWang AC, Cao JJ, Zheng H, Lu Z, Peiper SC, LiWang PJ.
    Biochemistry; 1999 Jan 05; 38(1):442-53. PubMed ID: 9890927
    [Abstract] [Full Text] [Related]

  • 19. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
    Weber KS, Gröne HJ, Röcken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C.
    Eur J Immunol; 2001 Aug 05; 31(8):2458-66. PubMed ID: 11500830
    [Abstract] [Full Text] [Related]

  • 20. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
    Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Lüttichau HR, Gerstoft J, Clapham PR, Clark-Lewis I, Wells TN, Schwartz TW.
    Science; 1997 Sep 12; 277(5332):1656-9. PubMed ID: 9287217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.